{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:34:30Z","timestamp":1771943670975,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185398","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T17:31:42Z","timestamp":1506447102000},"page":"e0185398","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Validation of participant eligibility for pre-exposure prophylaxis: Baseline data from the PRELUDE demonstration project"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-4110","authenticated-orcid":true,"given":"Stefanie J.","family":"Vaccher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Grulich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget G.","family":"Haire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian P.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isobel M.","family":"Poynten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna B.","family":"Zablotska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the PRELUDE Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"VA Fonner","year":"2016","journal-title":"AIDS"},{"issue":"27","key":"ref2","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"RM Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"JM Molina","year":"2015","journal-title":"N Engl J Med"},{"issue":"10013","key":"ref4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"S McCormack","year":"2015","journal-title":"Lancet"},{"key":"ref5","article-title":"Integrated delivery of PrEP and ART results in sustained near elimination of HIV transmission in African HIV serodiscordant couples: final results from The Partners Demonstration Project","author":"JM Baeten","year":"2016","journal-title":"AIDS2016"},{"issue":"9883","key":"ref6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"K Choopanya","year":"2013","journal-title":"The Lancet"},{"key":"ref7","article-title":"FDA approves first drug for reducing the risk of sexually acquired HIV infection","year":"2012"},{"key":"ref8","unstructured":"US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States 2014- A clinical practice guideline [Internet]. CDC; 2015 [cited 4 Apr 2016]. https:\/\/www.cdc.gov\/hiv\/pdf\/prepguidelines2014.pdf<\/ext-link>"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4102\/sajhivmed.v17i1.455","article-title":"Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection","volume":"17","author":"LG Bekker","year":"2016","journal-title":"S Afr J HIV Med"},{"key":"ref10","unstructured":"ASHM. Australian Commentary: US Public Health Service Clinical Practice Guidelines on Prescribing PrEP [Internet]. 2015 [cited 4 Apr 2016]. http:\/\/arv.ashm.org.au\/images\/Australian_National_PrEP_Guidelines.PDF<\/ext-link>."},{"key":"ref11","unstructured":"European AIDS Clinical Society. EACS Guidelines [Internet]. 2015 [cited 4 Apr 2016]. http:\/\/www.eacsociety.org\/files\/guidelines_8_0-english_web.pdf<\/ext-link>"},{"key":"ref12","article-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","year":"2015"},{"key":"ref13","article-title":"The likely impact of PrEP on HIV epidemics among men who have sex with men","author":"I. Zablotska","year":"2016","journal-title":"Sex Health"},{"issue":"4 Suppl 3","key":"ref14","doi-asserted-by":"crossref","first-page":"19949","DOI":"10.7448\/IAS.18.4.19949","article-title":"The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention","volume":"18","author":"CF Caceres","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/QAD.0000000000000591","article-title":"Estimating the range of potential epidemiological impact of pre-exposure prophylaxis: run-away success or run-away failure?","volume":"29","author":"I Cremin","year":"2015","journal-title":"AIDS"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QAI.0000000000000555","article-title":"Targeting pre-exposure prophylaxis among men who have sex with men in the United States and peru: partnership types, contact rates, and sexual role","volume":"69","author":"NB Carnegie","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/apc.2015.0113","article-title":"A latent class analysis of risk factors for acquiring HIV among men who have sex with men: implications for implementing pre-exposure prophylaxis programs","volume":"29","author":"PA Chan","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s15010-015-0850-2","article-title":"HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans","volume":"44","author":"CD Spinner","year":"2015","journal-title":"Infection"},{"key":"ref19","first-page":"125","article-title":"Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review","volume":"7","author":"J Wilton","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"ref20","first-page":"241","article-title":"Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence\u2014a narrative review","author":"B. Haire","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"ref21","unstructured":"The Kirby Institute. HIV, viral hepititis and sexually transmissible infections in Australia in Annual Surveillance Report. Sydney: UNSW Sydney; 2016."},{"key":"ref22","unstructured":"Therapeutic Goods Administration, Public Summary: TRUVADA tenofovir disoproxil fumarate\/emtricitabine 300\/200mg tablet bottle [Internet]. TGA [cited 10 Aug 2016]. https:\/\/www.ebs.tga.gov.au\/servlet\/xmlmillr6?dbid=ebs\/PublicHTML\/pdfStore.nsf&docid=107072&agid=(PrintDetailsPublic)&actionid=1<\/ext-link> ()."},{"key":"ref23","unstructured":"Pharmaceutical Benefits Advisory Committee. July 2016 PBAC outcomes\u2013 1st time decisions not to recommend [Internet]. PBAC [cited 07 Oct 2016]. http:\/\/www.pbs.gov.au\/industry\/listing\/elements\/pbac-meetings\/pbac-outcomes\/2016-07\/first-time-decisions-not-to-recommend-2016-07.pdf<\/ext-link>."},{"key":"ref24","unstructured":"Zablotska I. Pre-Exposure Prophylaxis of HIV with antiretroviral medications Interim NSW Guidelines [Internet]. NSW PrEP Guidelines and clinical delivery group [cited 4 Apr 2016]. http:\/\/www.cdc.gov\/hiv\/pdf\/prepguidelines2014.pdf<\/ext-link>."},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e32831fb51a","article-title":"Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men","volume":"23","author":"F Jin","year":"2009","journal-title":"AIDS"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/QAI.0b013e3181b48f33","article-title":"Anal sexually transmitted infections and risk of HIV infection in homosexual men","volume":"53","author":"F Jin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"17","key":"ref27","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/QAD.0b013e32833202b8","article-title":"Circumcision and risk of HIV infection in Australian homosexual men","volume":"23","author":"DJ Templeton","year":"2009","journal-title":"AIDS"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1468-1293.2010.00833.x","article-title":"Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings","volume":"11","author":"IM Poynten","year":"2010","journal-title":"HIV Med"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"e012179","DOI":"10.1136\/bmjopen-2016-012179","article-title":"Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE","volume":"6","author":"S Vaccher","year":"2016","journal-title":"BMJ Open"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"JR Landis","year":"1977","journal-title":"Biometrics"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"ML McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/cid\/civ778","article-title":"No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting","volume":"61","author":"JE Volk","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref33","first-page":"79","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services","volume":"176","author":"AY Liu","year":"2015","journal-title":"JAMA Internal Medicine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13063-016-1286-4","article-title":"An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis","volume":"17","author":"DI Dolling","year":"2016","journal-title":"Trials"},{"key":"ref35","unstructured":"Hull P, Limin M, Kolstee J, Duck T, Prestage G, Zablotska I, et al. Gay Community Periodic Survey Sydney 2015. Sydney: Centre for Social Research in Health, UNSW Sydney; 2016."},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of hiv transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy","volume":"316","author":"AJ Rodger","year":"2016","journal-title":"JAMA"},{"key":"ref37","unstructured":"Grulich AE, Bavinton B, Jin F, Prestage G, Zablotska I, Grinsztejn B, et al. on behalf of the Opposites Attract Study Group. HIV transmission in male serodiscordant couples in Australia, Thailand and Brazil. CROI 2015; 2015; Washington, Seattle (USA). Poster 1019LB."},{"key":"ref38","unstructured":"Zablotska I, Grulich AE, Guy R, Amin J, Selvey C, Schmidt HM, et al. on behalf of the EPIC-NSW Study Group. Expanded PrEP implementation in communities in NSW, Australia (EPIC-NSW): evidence-based implementation study. AIDS2016; 2016; Durban (South Africa). Abstract FRAE0105."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T08:40:39Z","timestamp":1603010439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185398"}},"subtitle":[],"editor":[{"given":"Alash'le G.","family":"Abimiku","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185398","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]}}}